Home / Inspections / 1110089

FDA Inspection 1110089 — Reproductive Gynecology Laboratories

Reproductive Gynecology Laboratories — FEI 3003928276

The FDA completed an inspection of Reproductive Gynecology Laboratories on November 7, 2019 in Akron, OH. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
November 7, 2019
Fiscal Year
2020
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Akron, OH (United States)

Facility

Other inspections at this facility

  • 1312310 (NAI Tue Apr 07 2026 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1194799 (NAI Tue Jan 10 2023 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1032534 (NAI Tue Nov 28 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 903327 (NAI Thu Nov 13 2014 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 813223 (VAI Tue Jan 15 2013 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources